NewEdge Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,916
Closed -$702K 4233
2025
Q4
$702K Sell
6,916
-19,783
-74% -$1.59M ﹤0.01% 1719
2025
Q3
$472K Buy
26,699
+21,847
+450% +$1.09M ﹤0.01% 1856
2025
Q2
$258K Buy
4,852
+4,129
+571% +$210K ﹤0.01% 2100
2025
Q1
$31.3K Sell
723
-3,266
-82% -$165K ﹤0.01% 2705
2024
Q4
$224K Sell
3,989
-7,911
-66% -$492K ﹤0.01% 2033
2024
Q3
$811K Buy
11,900
+9,522
+400% +$537K 0.01% 1200
2024
Q2
$100K Sell
2,378
-4,315
-64% -$237K ﹤0.01% 2116
2024
Q1
$462K Sell
6,693
-678
-9% -$42.9K ﹤0.01% 1389
2023
Q4
$545K Sell
7,371
-160
-2% -$10.5K 0.01% 1238
2023
Q3
$514K Sell
7,531
-830
-10% -$70.4K 0.01% 1157
2023
Q2
$785K Buy
8,361
+702
+9% +$54.8K 0.01% 981
2023
Q1
$519K Sell
7,659
-1,048
-12% -$67.4K 0.01% 1097
2022
Q4
$49.3K Sell
8,707
-2,113
-20% -$86.3K ﹤0.01% 1722
2022
Q3
$352K Buy
+10,820
New +$446K 0.01% 1119
2021
Q4
Sell
-2,274
Closed -$217K 1657
2021
Q3
$217K Sell
2,274
-166
-7% -$17.5K 0.01% 1026
2021
Q2
$303K Buy
2,440
+139
+6% +$16.6K 0.01% 900
2021
Q1
$303K Buy
+2,301
New +$315K 0.01% 807
2020
Q4
Sell
-4,749
Closed -$484K 1019
2020
Q3
$484K Buy
+4,749
New +$410K 0.02% 584
2020
Q2
Sell
-7,174
Closed -$416K 887
2020
Q1
$416K Buy
+7,174
New +$582K 0.02% 505
2018
Q4
Sell
-2,820
Closed -$223K 652
2018
Q3
$223K Buy
+2,820
New +$184K 0.02% 586

Other funds holding EXAS

NewEdge Advisors's EXAS Position: Q1 2026 in Review

NewEdge Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,916 shares — an estimated $702K sold.

NewEdge Advisors first reported a position in EXAS in Q3 2018 and held it in 20 quarters. The position peaked at $811K in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • NewEdge Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • NewEdge Advisors sold 6,916 Exact Sciences shares in Q1 2026, an estimated $702K.
  • NewEdge Advisors first reported a position in Exact Sciences in Q3 2018 and held it in 20 quarters.
  • NewEdge Advisors's Exact Sciences position peaked at $811K in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.